We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

150 hedge funds and large institutions have $648M invested in Collegium Pharmaceutical in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

338% more call options, than puts

Call options by funds: $2.54M | Put options by funds: $579K

7% more capital invested

Capital invested by funds: $603M → $648M (+$44.3M)

9% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 55

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.06% less ownership

Funds ownership: 107.86% → 107.81% (-0.06%)

6% less funds holding

Funds holding: 159 → 150 (-9)

35% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 26

Holders
150
Holders Change
-9
Holders Change %
-5.66%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
60
Reduced
55
Closed
26
Calls
$2.54M
Puts
$579K
Net Calls
+$1.96M
Net Calls Change
+$1.67M

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$14M
2
PA
Perceptive Advisors
New York
+$9.91M
3
IECM
Intrinsic Edge Capital Management
Illinois
+$8.14M
4
BlackRock
BlackRock
New York
+$6.24M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$4.11M

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$7.3M
2
DCM
Driehaus Capital Management
Illinois
-$5.16M
3
UBS AM
UBS AM
Illinois
-$4.4M
4
EA
Emerald Advisers
Pennsylvania
-$3.67M
5
Franklin Resources
Franklin Resources
California
-$3.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$4.56M -$2.42M -123,727 -32%
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$4.07M +$57.5K +2,936 +1%
Morgan Stanley
28
Morgan Stanley
New York
$4.05M -$2.44M -124,777 -35%
JGC
29
J. Goldman & Co
New York
$3.81M -$3.07M -156,588 -42%
LPL Financial
30
LPL Financial
California
$3.71M -$31.8K -1,622 -0.8%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.29M +$39.4K +2,013 +1%
WG
32
Winton Group
United Kingdom
$3.1M +$1.07M +54,473 +45%
Federated Hermes
33
Federated Hermes
Pennsylvania
$2.24M -$2.55M -130,270 -50%
FA
34
Friess Associates
Delaware
$2.2M +$2.47M +125,926 New
MSL
35
Mackay Shields LLC
New York
$2.11M +$1.59M +81,400 +209%
Two Sigma Investments
36
Two Sigma Investments
New York
$1.97M -$1.36M -69,375 -38%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$1.94M +$597K +30,500 +38%
AllianceBernstein
38
AllianceBernstein
Tennessee
$1.83M – – –
Neuberger Berman Group
39
Neuberger Berman Group
New York
$1.77M +$489K +25,000 +33%
Schroder Investment Management Group
40
Schroder Investment Management Group
United Kingdom
$1.75M +$461K +23,525 +31%
GC
41
Globeflex Capital
California
$1.74M +$18.5K +944 +1%
PPA
42
Parametric Portfolio Associates
Washington
$1.61M -$484K -24,746 -21%
Wells Fargo
43
Wells Fargo
California
$1.56M +$259K +13,227 +17%
Ameriprise
44
Ameriprise
Minnesota
$1.53M +$27.1K +1,383 +2%
Charles Schwab
45
Charles Schwab
California
$1.5M +$97.3K +4,969 +6%
Natixis Advisors
46
Natixis Advisors
Massachusetts
$1.49M +$210K +10,751 +14%
Skandinaviska Enskilda Banken (SEB)
47
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.45M +$121K +6,200 +8%
Goldman Sachs
48
Goldman Sachs
New York
$1.37M -$575K -29,367 -27%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$1.35M +$114K +5,844 +8%
1CM
50
1492 Capital Management
Wisconsin
$1.33M +$724K +36,997 +95%
1
2
3 4 5

COLL Hedge Fund Activity: Q2 2020 in Review

150 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2020, worth a combined $648M — up 7.3% from $603M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of COLL and 17 opened new positions — a net loss of 9 holders — while 55 trimmed existing stakes and 60 added.

The largest buyer was Rubric Capital Management (New York), adding an estimated $14M. The largest seller was Vivo Capital, exiting entirely with an estimated $7.3M sold.

  • 150 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2020, down from 159 in Q1 2020.
  • Funds reported $648M of Collegium Pharmaceutical stock for Q2 2020, up 7.3% quarter-over-quarter.
  • 17 funds opened new Collegium Pharmaceutical positions in Q2 2020 and 26 closed out, a net change of -9 holders.
  • The largest Collegium Pharmaceutical buyer in Q2 2020 was Rubric Capital Management (New York), an estimated $14M added.
  • The largest Collegium Pharmaceutical seller in Q2 2020 was Vivo Capital, an estimated $7.3M sold.

Based on aggregated 13F filings for Q2 2020.